Evaluating the efficacy of an integrated smoking cessation intervention for mental health patients: study protocol for a randomised controlled trial

Trials

John Wiggers⁶  Judith J Prochaska²  John Allan³  Megan Freund⁶  Luke Wolfenden⁶  Margarett Terry¹  Richard Clancy⁵  Maree Adams⁷  Emily Stockings⁴  Paula Wye⁶  Jenny A Bowman⁴  Alexandra P Metse⁷ 

[1] Mental Health and Substance Use Service, Mater Hospital, Cnr Edith and Platt Streets, Waratah, NSW 2298, Australia;Stanford Prevention Research Centre, Medical School Office Building, 1265 Welch Road, Mail Code 5411, Stanford, CA 94305-5411, USA;Mental Health and Drug and Alcohol Office, NSW Department of Health, 73 Miller Street, North Sydney, NSW 2060, Australia;Hunter Medical Research Institute, Lot 1 Kookaburra Circuit, New Lambton Heights, NSW 2305, Australia;Centre for Translational Neuroscience and Mental Health, Mater Hospital, Cnr Edith and Platt Streets, Waratah, NSW 2298, Australia;Hunter New England Population Health, Longworth Ave, Wallsend, NSW 2287, Australia;University of Newcastle, University Drive, Callaghan, NSW 2308, Australia

关键词: Multimodal intervention;    Community;    Inpatient;    Mental illness;    Smoking cessation;   

Others  :  829296
DOI  :  10.1186/1745-6215-15-266

 received in 2014-03-06, accepted in 2014-06-17,  发布年份 2014

【 摘 要 】

Background

Smoking rates, and associated negative health outcomes, are disproportionately high among people with mental illness compared to the general population. Smoke-free policies within mental health hospitals can positively impact on patients’ motivation and self-efficacy to address their smoking. However, without post-discharge support, preadmission smoking behaviours typically resume. This protocol describes a randomised controlled trial that aims to assess the efficacy of linking mental health inpatients to community-based smoking cessation supports upon discharge as a means of reducing smoking prevalence.

Methods/Design

Eight hundred participants with acute mental illness will be recruited into the randomised controlled trial whilst inpatients at one of four psychiatric inpatient facilities in the state of New South Wales, Australia. After completing a baseline interview, participants will be randomly allocated to receive either: ‘Supported Care’, a multimodal smoking cessation intervention; or ‘Normal Care’, consisting of existing hospital care only. The ‘Supported Care’ intervention will consist of a brief motivational interview and a package of self-help material for abstaining from smoking whilst in hospital, and, following discharge, 16 weeks of motivational telephone-based counselling, 12 weeks of free nicotine replacement therapy, and a referral to the Quitline. Data will be collected at 1, 6 and 12 months post-discharge via computer-assisted telephone interview. The primary outcomes are abstinence from smoking (7-day point prevalence and prolonged cessation), and secondary outcomes comprise daily cigarette consumption, nicotine dependence, quit attempts, and readiness to change smoking behaviour.

Discussion

If shown to be effective, the study will provide evidence in support of systemic changes in the provision of smoking cessation care to patients following discharge from psychiatric inpatient facilities.

Trial registration

Australian New Zealand Clinical Trials Registry ANZTCN:ACTRN12612001042831. Date registered: 28 September 2012.

【 授权许可】

   
2014 Metse et al.; licensee BioMed Central Ltd.

【 图 表 】

Figure 1.

【 参考文献 】

• [1]Lim SS, Vos T, Flaxman AD, Danaei G, Shibuya K, Adair-Rohani H, Amann M, Anderson HR, Andrews KG, Aryee M, Atkinson C, Bacchus LJ, Bahalim AN, Balakrishnan K, Balmes J, Barker-Collo S, Baxter A, Bell ML, Blore JD, Blyth F, Bonner C, Borges G, Bourne R, Boussinesq M, Brauer M, Brooks P, Bruce NG, Brunekreef B, Bryan-Hancock C, Bucello C: A comparative risk assessment of burden of disease and injury attributable to 67 risk factors and risk factor clusters in 21 regions, 1990–2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet 2012, 380:2224-2260.
• [2]Australian Institute of Health and Welfare: 2010 National Drug Strategy Household Survey report. Drug statistics series no. 25. Cat. no. PHE 145. Canberra: AIHW; 2011.
• [3]Lawrence D, Mitrou F, Zubrick SR: Smoking and mental illness: results from population surveys in Australia and the United States. BMC Public Health 2009, 9:285.
• [4]Reichler H, Baker A, Lewin T, Carr V: Smoking among in-patients with drug-related problems in an Australian psychiatric hospital. Drug Alcohol Rev 2001, 20:231-237.
• [5]de Leon J, Diaz FJ: A meta-analysis of worldwide studies demonstrates an association between schizophrenia and tobacco smoking behaviors. Schizophr Res 2005, 76:135-157.
• [6]Lasser K, Boyd W, Woolhandler S, Himmelstein D, McCormick D, Bor DH: Smoking and mental illness: a population based study. JAMA 2000, 284:606-610.
• [7]Bowden JA, Miller CL, Hiller JE: Smoking and mental illness: a population study in South Australia. Aust N Z J Psychiatry 2011, 45:325-331.
• [8]Lawrence D, Holma D, Jablensky A: Preventable Physical Illness in People with Mental Illness. Perth: University of Western Australia; 2001.
• [9]Colton CW, Manderscheid RW: Congruencies in increased mortality rates, years of potential life lost, and causes of death among public mental health clients in eight states. Prev Chronic Dis 2006, 3:A42.
• [10]Lancet: Smoke alarm: mental illness and tobacco. Lancet 2013, 381:1071.
• [11]Royal College of Physicians, Royal College of Psychiatrists: Smoking And Mental Health. London: RCP Council Report CR178; 2013.
• [12]Fiore MC, Jaen CR, Baker TB: Treating Tobacco Use and Dependence: 2008 update. Clinical Practice Guideline. Rockville, MD: Department of Health and Human Services: Public Health Service; 2008.
• [13]West R, McNeill A, Raw M: Smoking cessation guidelines for health professionals: an update. Thorax 2000, 55:987-999.
• [14]Banham L, Gilbody S: Smoking cessation in severe mental illness: what works? Addiction 2010, 105:1176-1189.
• [15]McFall M, Saxon AJ, Malte CA, Chow B, Bailey S, Baker DG, Beckham JC, Boardman KD, Carmody TP, Joseph AM, Smith MW, Shih MC, Lu Y, Holodniy M, Lavori PW: Integrating tobacco cessation into mental health care for posttraumatic stress disorder: a randomized controlled trial. JAMA 2010, 304:2485-2493.
• [16]Nohlert E, Ohrvik J, Tegelberg A, Tillgren P, Helgason AR: Long-term follow-up of a high- and a low-intensity smoking cessation intervention in a dental setting - a randomized trial. BMC Public Health 2013, 13:592.
• [17]Rigotti NA, Clair C, Munafo MR, Stead LF: Interventions for smoking cessation in hospitalised patients. Cochrane Database Syst Rev 2012., 5CD001837
• [18]Lemmens V, Oenema A, Knut IK, Brug J: Effectiveness of smoking cessation interventions among adults: a systematic review of reviews. Eur J Cancer Prev 2008, 17:535-544.
• [19]Prochaska JJ: Ten critical reasons for treating tobacco dependence in inpatient psychiatry. J Am Psych Nurse Ass 2009, 15:404-409.
• [20]Prochaska JJ, Hall SE, Delucchi K, Hall SM: Efficacy of initiating tobacco dependence treatment in inpatient psychiatry: a randomized controlled trial. Am J Public Health 2013, August, 15:e11-e19.
• [21]Cavazos-Rehg PA, Breslau N, Hatsukami D, Krauss MJ, Spitznagel EL, Grucza RA, Salyer P, Hartz SM, Bierut LJ: Smoking cessation is associated with lower rates of mood/anxiety and alcohol use disorders. Psychol Med 2014. Epub ahead of print, doi:10.1017/S0033291713003206
• [22]Taylor G, McNeill A, Girling A, Farley A, Lindson-Hawley N, Aveyard P: Change in mental health after smoking cessation: systematic review and meta-analysis. BMJ 2014, 348:g1151.
• [23]Wolfenden L, Wiggers J, Knight J, Campbell E, Rissel C, Kerridge R, Spigelman AD, Moore K: A programme for reducing smoking in pre-operative surgical patients: randomised controlled trial. Anaesthesia 2005, 60:172-179.
• [24]Freund MAG, Campbell EM, Paul CL, Wiggers JH, Knight JJ, Mitchell EN: Provision of smoking care in NSW hospitals: opportunities for further enhancement. NSW Public Health Bull 2008, 19:50-55.
• [25]New South Wales Department of Health: Smoke Free Workplace Policy Supplement, Circular 2004/51. Sydney, Australia: State Government of New South Wales; 2005.
• [26]New South Wales Department of Health: Guide For The Management Of Nicotine Dependent Inpatients: Summary Of Evidence. Sydney, Australia: State Government of New South Wales; 2002.
• [27]Prochaska JJ: Integrating tobacco treatment into mental health settings. JAMA 2010, 304:2354-2356.
• [28]Shmueli D, Fletcher L, Hall S, Hall S, Prochaska JJ: Changes in psychiatric patients’ thoughts about quitting smoking during a smoke-free hospitalization. Nicotine Tob Res 2008, 10:875-881.
• [29]Hennrikus DJ, Lando HA, McCarty MC, Klevan D, Holtan N, Huebsch JA, Jestus S, Pentel PR, Pine D, Sullivan S, Swenson K, Vessey J: The TEAM project: the effectiveness of smoking cessation intervention with hospital patients. Prev Med 2005, 40:249-258.
• [30]Prochaska JJ, Fletcher L, Hall S, Hall S: Return to smoking following a smoke-free psyhicatric hospitalization. Am J Addict 2006, 15:15-22.
• [31]Prochaska JJ, Hall SE, Hall SM: Stage-tailored tobacco cessation treatment in inpatient psychiatry. Psychiatr Serv 2009, 60:848.
• [32]Bowman J, Stockings E: Smoking cessation for hospitalised patients: intensive behavioural counselling started in hospital and continued after discharge increases quit rates; with additional benefit from adding nicotine replacement therapy. Evid Based Nurs 2012, 16:21-22.
• [33]Stockings E, Bowman J, Wiggers J, Baker A, Terry M, Clancy R, Wye P, Knight J, Moore L: A randomised controlled trial linking mental health inpatients to community smoking cessation supports: a study protocol. BMC Public Health 2011, 11:570.
• [34]Stockings EA, Bowman JA, Baker AL, Terry M, Clancy R, Wye PM, Knight J, Moore LH, Adams MF, Colyvas K, Wiggers JH: Impact of a post-discharge smoking cessation intervention for smokers admitted to an inpatient psychiatric facility: a randomised controlled trial. Nicotine Tob Res 2014. Epub ahead of print, doi:10.1093/ntr/ntu1097
• [35]Hedden S, Woolson R, Malcolm R: Randomization in substance abuse clinical trials. Subst Abuse Treat Prev Pol 2006, 1:6.
• [36]New South Wales Department of Health: Smoke-free Health Service Policy: Managing Nicotine Dependent Inpatients and Prospective Aged Care Residents. Sydney, Australia: State Government of New South Wales; 2009.
• [37]Wye P, Bowman J, Wiggers J, Baker A, Carr V, Terry M, Knight J, Clancy R: An audit of the prevalence of recorded nicotine dependence treatment in an Australian psychiatric hospital. Aust N Z J Public Health 2010, 34:298-303.
• [38]Wye P, Bowman JA, Wiggers JH, Baker A, Knight J, Carr VJ, Terry M, Clancy R: Smoking restrictions and treatment for smoking: policies and procedures in psychiatric inpatient units in Australia. Psychiatr Serv 2009, 60:100-107.
• [39]Lancaster T, Stead L: Self-help interventions for smoking cessation. Cochrane Database Syst Rev 2005., 3CD001118
• [40]SANE Australia: smoking and mental illness. http://www.sane.org/information/factsheets-podcasts/210-smoking-and-mental-illness webcite
• [41]Quit SA: Mental health. http://www.quitsa.org.au/aspx/mental_health.aspx webcite
• [42]Cancer Institute NSW: quitline. http://www.cancerinstitute.org.au/cancer_inst/programs/quitline.html webcite
• [43]Lai D, Cahill K, Qin Y, Tang J: Motivational interviewing for smoking cessation. Cochrane Database Syst Rev 2010., 1CD006936
• [44]Stead LF, Perera R, Lancaster T: Telephone counselling for smoking cessation. Cochrane Database Syst Rev 2006., 3CD002850
• [45]Stead LF, Perera R, Bullen C, Mant D, Lancaster T: Nicotine replacement therapy for smoking cessation. Cochrane Database Syst Rev 2008., 1CD000146
• [46]Miller WR: Motivational interviewing with problem drinkers. Behav Psychother 1983, 11:147-172.
• [47]Heatherton TF, Kozlowski LT, Frecker RC, Fagerstrom K-O: The Fagerstrom test for nicotine dependence: a revision of the Fagerstrom tolerance questionnaire. Br J Addict 1991, 86:1119-1127.
• [48]Hughes JR, Hatsukami DK: Signs and symptoms of tobacco withdrawal. Arch Gen Psychiatry 1986, 43:289-294.
• [49]Bittoun R: A combination nicotine replacement therapy (NRT) algorithm for hard-to-treat smokers. J AASCP 2006, 1:3-6.
• [50]West R, Hajek P, Stead L, Stapleton J: Outcome criteria in smoking cessation trials: proposal for a common standard. Addiction 2005, 100:299-303.
• [51]Hung J, Lin CH, Wang JD, Chan CC: Exhaled carbon monoxide level as an indicator of cigarette consumption in a workplace cessation program in Taiwan. J Formos Med Assoc 2006, 105:210-213.
• [52]Crittenden KS, Manfredi C, Lacey L, Warnecke R, Parsons J: Measuring readiness and motivation to quit smoking among women in public health clinics. Addict Behav 1994, 19:497-507.
• [53]West R: Theory of Addiction. Oxford, UK: Blackwell; 2006.
• [54]Babor TF, Higgins-Biddle JC, Saunders JB, Monteiro MG: The Alcohol Use Disorders Identification Test Guidelines for Use in Primary Care. Geneva: World Health Organization; 1990.
• [55]Kessler RC, Andrews G, Colpe LJ, Hiripi E, Mroczek DK, Normand S-LT, Walters EE, Zaslavsky AM: Short screening scales to monitor population prevalences and trends in non-specific psychological distress. Psychol Med 2002, 32:959-976.
• [56]Cohen S, Kamarck T, Mermelstein R: A global measure of perceived stress. J Health Soc Behav 1983, 24:385-396.
• [57]Fagerstrom K, Russ C, Yu CR, Yunis C, Foulds J: The Fagerstrom Test for Nicotine Dependence as a predictor of smoking abstinence: a pooled analysis of varenicline clinical trial data. Nicotine Tob Res 2012, 14:1467-1473.
• [58]Pagoto SL, Kozak AT, John P, Bodenlos JS, Hedeker D, Spring B, Schneider KL: Intention-to-treat analyses in behavioral medicine randomized clinical trials. Int J Behav Med 2009, 16:316-322.